Found: 5
Select item for more details and to access through your institution.
Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs.
- Published in:
- Pharmacology Research & Perspectives, 2018, v. 6, n. 6, p. 1, doi. 10.1002/prp2.447
- By:
- Publication type:
- Article
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2009, v. 36, n. 6, p. 585, doi. 10.1007/s10928-009-9139-3
- By:
- Publication type:
- Article
A phase 1 healthy male volunteer single escalating dose study of the pharmacokinetics and pharmacodynamics of risdiplam (RG7916, RO7034067), a SMN2 splicing modifier.
- Published in:
- British Journal of Clinical Pharmacology, 2019, v. 85, n. 1, p. 181, doi. 10.1111/bcp.13786
- By:
- Publication type:
- Article
Characterization of the Transmembrane Transport and Absolute Bioavailability of the HCV Protease Inhibitor Danoprevir.
- Published in:
- Clinical Pharmacokinetics, 2015, v. 54, n. 5, p. 537, doi. 10.1007/s40262-014-0222-6
- By:
- Publication type:
- Article
Prediction of Pharmacokinetic Profile of Valsartan in Humans Based on in vitro Uptake-Transport Data.
- Published in:
- Chemistry & Biodiversity, 2009, v. 6, n. 11, p. 1975, doi. 10.1002/cbdv.200900116
- By:
- Publication type:
- Article